Lymph in Medical Technology
Navigation Links
Lymph in Medical Technology
... and women equally. The cancer involves the body's lymph nodes which fight infection and disease. It begins with an enlargement of the lymph nodes and symptoms can include fever, weight ... It is called "follicular" lymphoma because lymph nodes seen under microscopes display unusual ...
... 87 percent of the patients had undergone lymph node dissection, 70 percent had received ... lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, ... after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated ...
... only (n=629) within 70 days of regional lymph node dissection (intent-to-treat population). The ... in patients with a lower tumor burden in the lymph nodes based on predefined subgroups. For the ... with clinically non-palpable (microscopic) lymph node disease, the HR for RFS was 0.73 (99 percent ...
... the cells of the lymphatic system, which is composed of lymphoid tissue, lymph vessels and lymph fluid that help the body filter out bacteria and fight disease. Since ...
... treatment prior to surgery. Patients who present with tumor containing lymph nodes are particularly difficult to treat and approximately half of these ... by direct injection, at three dose levels, into tumor containing lymph nodes in combination with standard first line chemo radiotherapy every ...
... immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue and other organs. Roughly 90,000 people in the United States are ... immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue and other organs. Two types of lymphocytes are present in the ...
... candidates for alemtuzumab due to bulky tumor masses in their lymph nodes (bulky fludarabine refractory; BFR). The primary endpoint ... candidates for alemtuzumab due to bulky tumor masses in their lymph nodes. The study design calls for patients to receive eight weekly ...
... inappropriate candidates for alemtuzumab due to bulky tumor in their lymph nodes. An objective response rate of 51% (p<0.0001) consisting of 30 ... inappropriate candidates for alemtuzumab due to bulky tumor in their lymph nodes. All patients in the study receive 8 weekly infusions of ofatumumab, ...
... swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for ... patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that 6 percent to 40 ...
... pain, swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. In over 2,000 XIAFLEX injections administered in ... pain, swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. These adverse events were consistent with previous ...
... swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for ... patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that 6 percent to 40 ...
... through the wall of the colon or rectum but has not yet spread to nearby lymph nodes. In Stage III, the cancer has invaded one or more of the local lymph nodes but has not spread to distant sites. Metastatic colorectal cancer ...
... 67% and was as high as 98%. Two patients with leukemia cutis had complete or partial clearance of skin lesions. One patient had a 36% reduction in lymph node size, a 28% decrease in spleen size and a significant increase (44%) in hemoglobin. Mild grade 1 or 2 infusion toxicity was observed and there ...
... cancer accounts for around 85% of all lung cancers(5). If lung cancer is detected at early stages, before it has spread to other organs or lymph nodes, around half of patients can survive for five years or more. However, few lung cancers are found at this early stage and it is normally ...
... and 23 cases were HER-2/neu positive. Scientists found that the increased expression of EZH-2 meant an increase in tumor size and an increase in lymph node metastasis. Dr. Nahleh said that increased identification of proteins in these aggressive forms of breast cancer is needed to develop ...
... In RCC, cancer cells develop in the lining of the kidney's tubes and grow into a tumor(8). If left untreated, the tumor can spread to neighboring lymph nodes and eventually other organs(9). RECORD-1 trial The FDA regulatory filing for Afinitor was based on data from RECORD-1 ( RE nal C ell ...
... Phase III study that enrolled 1,803 premenopausal women with estrogen receptor-positive Stage I or II breast cancer, with fewer than 10 axillary lymph nodes involved. Patients were recruited for the study after curative surgery and initiation of goserelin treatment for ovarian suppression, and ...
... (Molecular Grade Index), two molecular biomarkers that refine and improve risk stratification in patients with estrogen receptor (ER)-positive, lymph node-negative breast cancer. Data presented at the San Antonio meeting this week provide further evidence that the Theros BCI is a valuable ...
... begin growing abnormally and divide more rapidly than healthy cells. The quick division of cells may cause spreading through the breast, to the lymph nodes or to other parts of the body. About RAD001 RAD001, an oral once-daily inhibitor of mTOR, is an investigational drug being ...
... on REAL classification plus one or more of the following criteria: LDH>2xULN (IU/I), Stage III-IV disease or Stage I-III disease with at least one lymph node/tumor >5 cm. Visit www.elitek.com for more information about Elitek(R). About sanofi-aventis Sanofi-aventis, a ...
... -- between central IHC and quantitative RT-PCR using Oncotype DX for determining HER2 status. The study analyzed 755 patients with 0 to 3 positive lymph nodes who were enrolled in Intergroup study E2197, a large adjuvant breast cancer trial evaluating two different chemotherapy regimens. The second ...
... response mediated by anti-cancer Natural Killer (NK) cells, CD8+ lymphocytes and NK-T cells. This results in the activation of tumor-draining lymph nodes, cellular infiltration of distant tumors and tumor-cell death. Mounting the initial immune response in the GALT -- away from the primary tumor ...
... begin growing abnormally and divide more rapidly than healthy cells. The quick division of cells may cause spreading through the breast, to the lymph or to other parts of the body. About RAD001 RAD001, an oral inhibitor of mTOR, is an investigational drug being studied in multiple tumor types. ...
Breast MRI Scan Could Determine Need for Radiation Therapy
... For women whose breast cancer has spread to their lymph nodes, a magnetic resonance imaging (MRI) scan ... based findings of cancer having spread to lymph nodes. This suggests that breast MRI could ... the surgery to remove the cancer and sample the lymph nodes, you reduce your ability to know whether ...... 87 percent of the patients had undergone lymph node dissection, 70 percent had received ... lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, ... after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated ...
... only (n=629) within 70 days of regional lymph node dissection (intent-to-treat population). The ... in patients with a lower tumor burden in the lymph nodes based on predefined subgroups. For the ... with clinically non-palpable (microscopic) lymph node disease, the HR for RFS was 0.73 (99 percent ...
Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
... these patients often depends upon the degree of lymph node involvement and whether the cancer has ... found that once the T-cells returned to the lymph nodes and spleen, the virus detached itself from ... if you use this virus to kill tumor cells in the lymph nodes, you get a higher immunity against ...Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
... regimen. The study included 226 women with lymph node positive breast cancer who have had already ... surgical removal (mastectomy) of the lesion and lymph node dissection. The study was sponsored by the ... apparent cardiac dysfunction in patients with lymph node positive breast cancer treated with ...... the cells of the lymphatic system, which is composed of lymphoid tissue, lymph vessels and lymph fluid that help the body filter out bacteria and fight disease. Since ...
... treatment prior to surgery. Patients who present with tumor containing lymph nodes are particularly difficult to treat and approximately half of these ... by direct injection, at three dose levels, into tumor containing lymph nodes in combination with standard first line chemo radiotherapy every ...
Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis
... or absence of ulceration, and whether the melanoma has spread to the lymph nodes or other organs. For example, if a tumor is less than 1 mm in depth ... deeper than 1 mm, Dr. Driscoll advised that a procedure known as sentinel lymph node mapping and biopsy should be considered. This procedure has not been ...... immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue and other organs. Roughly 90,000 people in the United States are ... immature white blood cells (lymphocytes) in the bone marrow, blood, lymph tissue and other organs. Two types of lymphocytes are present in the ...
... candidates for alemtuzumab due to bulky tumor masses in their lymph nodes (bulky fludarabine refractory; BFR). The primary endpoint ... candidates for alemtuzumab due to bulky tumor masses in their lymph nodes. The study design calls for patients to receive eight weekly ...
... inappropriate candidates for alemtuzumab due to bulky tumor in their lymph nodes. An objective response rate of 51% (p<0.0001) consisting of 30 ... inappropriate candidates for alemtuzumab due to bulky tumor in their lymph nodes. All patients in the study receive 8 weekly infusions of ofatumumab, ...
... swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for ... patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that 6 percent to 40 ...
... pain, swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. In over 2,000 XIAFLEX injections administered in ... pain, swelling, bruising and pruritis at the injection site and transient lymph node swelling and pain. These adverse events were consistent with previous ...
... swelling of the upper and lower extremities due to the build-up of excess lymph fluid. This can occur when the lymphatic system, which is responsible for ... patients, this can occur after surgery, such as removal or biopsy of the lymph nodes, and/or radiation therapy. It is estimated that 6 percent to 40 ...
... through the wall of the colon or rectum but has not yet spread to nearby lymph nodes. In Stage III, the cancer has invaded one or more of the local lymph nodes but has not spread to distant sites. Metastatic colorectal cancer ...
... 67% and was as high as 98%. Two patients with leukemia cutis had complete or partial clearance of skin lesions. One patient had a 36% reduction in lymph node size, a 28% decrease in spleen size and a significant increase (44%) in hemoglobin. Mild grade 1 or 2 infusion toxicity was observed and there ...
... cancer accounts for around 85% of all lung cancers(5). If lung cancer is detected at early stages, before it has spread to other organs or lymph nodes, around half of patients can survive for five years or more. However, few lung cancers are found at this early stage and it is normally ...
... and 23 cases were HER-2/neu positive. Scientists found that the increased expression of EZH-2 meant an increase in tumor size and an increase in lymph node metastasis. Dr. Nahleh said that increased identification of proteins in these aggressive forms of breast cancer is needed to develop ...
... In RCC, cancer cells develop in the lining of the kidney's tubes and grow into a tumor(8). If left untreated, the tumor can spread to neighboring lymph nodes and eventually other organs(9). RECORD-1 trial The FDA regulatory filing for Afinitor was based on data from RECORD-1 ( RE nal C ell ...
Blood Testing Identifies Abnormal Cells Up to Six Years Prior to Leukemia Diagnosis
... progresses slowly over many years. In this disease, abnormal white blood cells called B-cells accumulate in the blood and the bone marrow. The lymph nodes, spleen, and other organs may also be affected. Although CLL is the most common form of leukemia in adults in Western countries, little is ...... Phase III study that enrolled 1,803 premenopausal women with estrogen receptor-positive Stage I or II breast cancer, with fewer than 10 axillary lymph nodes involved. Patients were recruited for the study after curative surgery and initiation of goserelin treatment for ovarian suppression, and ...
... (Molecular Grade Index), two molecular biomarkers that refine and improve risk stratification in patients with estrogen receptor (ER)-positive, lymph node-negative breast cancer. Data presented at the San Antonio meeting this week provide further evidence that the Theros BCI is a valuable ...
... begin growing abnormally and divide more rapidly than healthy cells. The quick division of cells may cause spreading through the breast, to the lymph nodes or to other parts of the body. About RAD001 RAD001, an oral once-daily inhibitor of mTOR, is an investigational drug being ...
... on REAL classification plus one or more of the following criteria: LDH>2xULN (IU/I), Stage III-IV disease or Stage I-III disease with at least one lymph node/tumor >5 cm. Visit www.elitek.com for more information about Elitek(R). About sanofi-aventis Sanofi-aventis, a ...
The Leukemia & Lymphoma Society and Memgen Announce New Chronic Lymphocytic Leukemia Clinical Trial
... patients with high risk and treatment-resistant CLL. Most importantly, ISF35 was well-tolerated with only minimal side effects, reduced CLL cells and lymph nodes in nearly every patient, and when combined with chemotherapy produced complete or partial remissions in patients with 17p deleted CLL." ...Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity
... is also part of the immune system that traps and attacks invading organisms and is a primary route for malignant tumor dissemination to the regional lymph nodes. "The new finding adds to a growing body of evidence showing that some fully differentiated cell types can exhibit great plasticity ...U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
... fever is a more serious form of disease which can include all of the symptoms of classic dengue fever plus noticeable damage to blood vessels and lymph vessels, bleeding from the nose and gums, and conspicuous bruising under the skin. Dengue hemorrhagic fever can lead to death. The most severe form ...Young Women Diagnosed with Early-Stage Breast Cancer More Likely to Die than Older Women
... MD, assistant professor of surgery, Washington University School of Medicine, St. Louis, MO, "These are women with similar size tumor and lymph node status. The characteristics of the tumor itself, however, portend a poorer prognosis. "We think we should devote much of our future research ...Susan G. Komen for the Cure(R) Makes Unprecedented Research and Local Program Grants
... the treatment of patients with advanced breast cancer. The majority of breast cancer deaths arise from the cancer spreading from the breast to lymph nodes and distant sites such as the lung and bone. Once the cancer spreads beyond the breast, the relative five-year survival rate drops from 98 to ...Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial
... to receive the single-dose radiation, they must be a candidate for the TARGIT Trial. Other considerations include type of cancer, tumor size, and lymph node involvement. To learn more, call 757-594- 1939 or visit http://www.sentara.com/cancer . ...Radioactive Seed Therapy Shows Significant Reduction in Lung Cancer Recurrence
... for an estimated 85% of all cases. Stage I NSCLC is characterized by disease that is localized in the lung with no metastasis to the lymph node system. "The standard of care for patients with this particular disease is a lobectomy, or surgical removal of the entire lobe of the lung. ...... -- between central IHC and quantitative RT-PCR using Oncotype DX for determining HER2 status. The study analyzed 755 patients with 0 to 3 positive lymph nodes who were enrolled in Intergroup study E2197, a large adjuvant breast cancer trial evaluating two different chemotherapy regimens. The second ...
Alexion Secures U.S. Patent for ALXN6000, a First-In-Class Anti-CD200 Monoclonal Antibody
... body. (3) B-cell CLL is characterized by clonal expansion of abnormal B lymphocytes. Patients with CLL also may develop enlargement of the spleen and lymph nodes, and pancytopenia (depletion of red and white blood cells and platelets), ultimately resulting in hemorrhage, infection and death. (4) About ...... response mediated by anti-cancer Natural Killer (NK) cells, CD8+ lymphocytes and NK-T cells. This results in the activation of tumor-draining lymph nodes, cellular infiltration of distant tumors and tumor-cell death. Mounting the initial immune response in the GALT -- away from the primary tumor ...
The Leukemia & Lymphoma Society and Memgen Collaborate on CLL Clinical Trial
... M.D., Ph.D., at The University of Texas M. D. Anderson Cancer Center, a single infusion of ISF35 resulted in the rapid decline in circulating and lymph node bound leukemic cells, induced long-term immune based responses against these cells and sensitized them to standard chemotherapies, even in ...Genetic Immunity to Present at 2008 BIO International Convention
... that includes disease-specific plasmid DNA encoded antigens. DermaPrep is the topical administration device that delivers NanoComp into a patient's lymph node dendritic cells to induce T cell mediated immune responses that can treat a broad spectrum of diseases. These two components together make up ...Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL
... large B-cell lymphoma is the most common type of NHL and is generally categorized as aggressive, marked by rapidly growing tumors in the lymph nodes, spleen, liver, bone marrow and other organs. A variety of treatment options exist, including chemotherapy and radiation, but the five-year ...Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy
... of better drugs to treat metastatic disease -- cancer that has spread beyond the prostate to distant sites throughout the body, such as bone, lymph nodes and internal organs. "So far we've targeted systemic, or circulating, androgens in men with advanced prostate cancer," Mostaghel said. "What ...... begin growing abnormally and divide more rapidly than healthy cells. The quick division of cells may cause spreading through the breast, to the lymph or to other parts of the body. About RAD001 RAD001, an oral inhibitor of mTOR, is an investigational drug being studied in multiple tumor types. ...
Other ContentsbackcrossbacteriophagebacteriophagebacteriophagebacteriophagebacteriophagesbacteriophagesbandbandbandbandbandbandbandbandbarkbarkbarkbarkbasesbasesbasesbasesbasesbasesbasophilsbasophilsOther TagsKansasAngledAngledSutureTennantJaffeOther Tagspersist 2persist 3persist 4simple 2simple 3simple 4simple 5simple 6simple 7simple 8simple 9simple 10relatively 2relatively 3relatively 4relatively 5relatively 6relatively 7relatively 8relatively 9relatively 10trace 2trace 3trace 4forward 2forward 3forward 4forward 5forward 6forward 7forward 8moves 2moves 3moves 4
(Date:12/15/2009)... German ., Despite the fact that physical ... vary as to how space is encoded in their ... such as ,left, right, front, back, to talk about ... east, west, at all times for all scales: "The ... an snake by your Northern leg". Whether not only ...
(Date:12/15/2009)... an enormous emotional and economic toll on society. It ... currents each year in U.S. waters and it,s likely that ... A serious disconnect exists between rip current research and ... tides and undertows, and more importantly, most people do not ... rip current. , The goal of the Rip Current Symposium ...
(Date:12/14/2009)... 14, 2009) -- Researchers at Rice University and Baylor ... that can be tracked in real time with MRI ... with a fluorescent dye and kills them with heat. ... from a growing field called "theranostics" that develops technologies ... a single procedure. , The research is available online ...
Breaking Biology News(10 mins):More than a jump to the left 2Tracking new cancer-killing particles with MRI 2Photos 3A First of Its Kind Website Unveiled at Modern Moms Meet Modern Science Meeting 59728 1Photos 3A First of Its Kind Website Unveiled at Modern Moms Meet Modern Science Meeting 59728 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 1AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 1Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 2Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 3Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 4Talecris Biotherapeutics Receives FDA Approval for PROLASTIN 28R 29 C 5548 5(Date:12/16/2009)... 8 percent of children are uninsured, government report finds ... first six months of this year, 45.4 million Americans ... population -- had no health insurance, according to new ... addition, 58.4 million (19.4 percent) people of all ages ... year prior to the interview, and 31.9 million (10.6 ...
(Date:12/16/2009)... A new software program developed by CareRise ... facilities to calculate their staffing needs as it relates ... allows inpatient healthcare facilities to calculate their mandatory nurse-to-patient ... and receive a daily report as to how it ... leader in risk management in the healthcare industry, has ...
(Date:12/16/2009)... a 1st century shrouded man found in a tomb on ... the earliest proven case of leprosy. Details of the research ... Journal. , The molecular investigation was undertaken by Prof. ... F. Kuvin Center for the Study of Infectious and Tropical ... and Ms. Kim Vernon of Lakehead University, Canada, Prof. Azriel ...
(Date:12/16/2009)... Fortune 1000 employers strongly indicates that wellness programs have a ... , ... Minneapolis, MN (PRWEB) December 16, ... that 78 percent of employers have improved employee participation in ... In the survey, conducted by Hallmark Insights, a leader ...
(Date:12/16/2009)... Dec. 16 For ages, people from around ... therapeutic properties. Its soothing waters have a reputation that ... its involvement with miracles. Now, with the introduction of ... bathers can enjoy the legendary benefits of Dead Sea ... salt lines contain all-natural Dead Sea salt and essential ...
Breaking Medicine News(10 mins):Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3[0] Over 45 Million Americans Now Lack Health Insurance[0] United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software[0] DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy[0] Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs [0] SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |